Abstract | BACKGROUND:
Polycystic liver disease ( PLD) causes symptoms resulting from cystic volume expansion. The PLD-specific questionnaire ( PLD-Q) captures symptom burden. This study aims to develop a threshold to identify patients with symptoms requiring further exploration and possibly intervention. METHODS: We recruited PLD patients with completed PLD-Qs during their patient journey. We evaluated baseline PLD-Q scores in (un)treated PLD patients to determine a threshold of clinical importance. We assessed our threshold's discriminative ability with receiver operator characteristic statistics, Youden Index, sensitivity, specificity, positive and negative predictive value parameters. RESULTS: We included 198 patients with a balanced proportion of treated (n=100) and untreated patients (n=98, PLD-Q scores 49 vs 19, p<0.001; median total liver volume 5827 vs 2185 ml, p<0.001). We established the PLD-Q threshold at 32 points. A score of ≥32 differentiates treated from untreated patients with an area under the ROC of 0.856, Youden Index 0.564, sensitivity of 85.0%, specificity of 71.4%, positive predictive value of 75.2%, and negative predictive value of 82.4%. Similar metrics were observed in predefined subgroups and an external cohort. CONCLUSION: We established the PLD-Q threshold at 32 points with high discriminative ability to identify symptomatic patients. Patients with a score ≥32 should be eligible for treatment or inclusion in trials.
|
Authors | Thijs R M Barten, Christian B Staring, Marie C Hogan, Tom J G Gevers, Joost P H Drenth, DIPAK consortium |
Journal | HPB : the official journal of the International Hepato Pancreato Biliary Association
(HPB (Oxford))
Vol. 25
Issue 8
Pg. 890-897
(08 2023)
ISSN: 1477-2574 [Electronic] England |
PMID | 37095030
(Publication Type: Journal Article)
|
Copyright | Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
Topics |
- Humans
- Liver Diseases
(diagnosis, therapy)
- Cysts
(diagnosis, therapy)
- Surveys and Questionnaires
|